Proteostasis Therapeutics Inc
Change company Symbol lookup
Select an option...
PTI Proteostasis Therapeutics Inc
CALB California BanCorp
$NOPM2 Refinitiv Norway Metal & Mining Inde
EBAY eBay Inc
PTON Peloton Interactive Inc
GO Grocery Outlet Holding Corp
NUE Nucor Corp
SJM J M Smucker Co
KR Kroger Co
HON Honeywell International Inc
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Proteostasis Therapeutics, Inc. is a clinical stage biopharmaceutical company. The Company is engaged in the discovery and development of novel therapeutics to treat cystic fibrosis (CF), and other diseases caused by an imbalance in the proteostasis network, a set of pathways that control protein biosynthesis, folding, trafficking and clearance. The Company focuses on identifying therapies that restore protein function. The Company’s CF focused pipeline consists of novel CFTR modulators including correctors, potentiators and amplifiers. The Company’s clinical developments include PTI-801, a third generation CFTR corrector, PTI-808, a CFTR potentiator, and PTI-428, a CFTR amplifier.

Postmarket

Last Trade
Delayed
$1.04
0.03 (2.97%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$1.01
Day's Change
-0.01 (-0.98%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
1.05
Day's Low
1.00
Volume
(Heavy Day)
Volume:
583,078

10-day average volume:
407,351
583,078

Activision Blizzard stock price target raised to $84 from $70 at Ascendiant Capital

6:12 am ET June 4, 2020 (MarketWatch)
Print

(END) Dow Jones Newswires

June 04, 2020 06:12 ET (10:12 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.